LXEO Lexeo Therapeutics, Inc. Common Stock
Healthcare$5.11-2.29%ClosedMarket Cap: $401.2M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$18.33
Target (Median)
$20.00
Target Range
$10.00 - $25.00
Upside from current price: 258.7%
Rating Distribution
2 Strong Buy9 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-11 | Chardan Capital | maintain | Buy | Buy |
| 2026-01-13 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-13 | Chardan Capital | maintain | Buy | Buy |
| 2025-12-11 | Chardan Capital | maintain | Buy | Buy |
| 2025-11-05 | Chardan Capital | maintain | Buy | Buy |
| 2025-10-21 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-07 | Leerink Partners | maintain | Outperform | Outperform |
| 2025-08-15 | Chardan Capital | maintain | Buy | Buy |
| 2025-08-15 | Leerink Partners | maintain | Outperform | Outperform |
| 2025-08-15 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-1.52 | $0.00 | 8 |
| Fri Dec 31 | $-1.26 | $8.6M | 7 |
| Sun Dec 31 | $-0.71 | $92.5M | 5 |
| Mon Dec 31 | $0.72 | $300.3M | 1 |